Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II-IIIA (8th edition TNM…
この記事を読む
記事一覧 18ページ
この記事を読む
EGFR遺伝子変異陽性の術後補助化学療法の層別化
Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non-Squamous Non-Small C…
この記事を読む
腫瘍サイズと免疫チェックポイント阻害薬
The effect of tumor size and metastatic extent on the efficacy of first line pembrolizumab monotherapy in patients with …
この記事を読む
EGFR遺伝子変異陽性、手術追加の意義は？
Thoracic surgery improved overall survival in patients with stage IIIB-IV epidermal growth factor receptor-mutant lung a…
この記事を読む
非扁平上皮癌の方がPD-L1発現とOSが相関しやすい？
Programmed Death-Ligand 1 Tumor Proportion Score and Overall Survival From First-Line Pembrolizumab in Patients With Non…
この記事を読む
アファチニブ→オシメルチニブの治療シークエンス
Sequential afatinib and osimertinib in patients with EGFR mutation-positive NSCLC and acquired T790M: A global non-inter…
この記事を読む
いわゆるオリゴメタに対する外科治療
The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cance…
この記事を読む
抗がん剤＋デノスマブ、統合解析でも有効集団見いだせず
Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line c…
この記事を読む
術後補助化学療法としてのゲフィチニブ
Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non-S…
この記事を読む
アファチニブ導入を低用量から行っても遜色ない効果
A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small…